Evidence map›Paper›PMID 24470501›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation.

Louise M D'Cruz, Martin H Stradner, Cliff Y Yang, Ananda W Goldrath

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. ILC Differentiation in the Thymus.Advances in experimental medicine and biology · 2022
    Article
  6. Review
  7. Article
  8. Genetic Analysis of iNKT Cell Development and Function.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Development of mucosal-associated invariant T cells.Immunology and cell biology · 2018
    Review
  19. Article
  20. Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Louise M D'CruzDivision of Biology, University of California San Diego, La Jolla, CA 92093.
Martin H Stradner
Cliff Y Yang
Ananda W Goldrath
University of California, San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
T cell maintenance: molecular mediators of the TCR-derived survival signalR01AI067545 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GOLDRATH, ANANDA W · 2006 to 2021
$6.1M
Regulation of T cell immunity to viral infectionR01AI072117 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GOLDRATH, ANANDA W · 2008 to 2022
$5.4M
T cell maintenance: molecular mediators of T cell differentiation and survivalR37AI067545 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ananda W Goldrath · 2022 to 2026
$3.0M
Regulation of Natural Killer T cell maturation, homeostasis and activationR00AI097286 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI D'CRUZ, LOUISE M. · 2014 to 2015
$492k
Regulation of Natural Killer T cell maturation, homeostasis and activationK99AI097286 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI D'CRUZ, LOUISE M. · 2012 to 2012
$90k
Austrian Science Fund FWF J 3189NCI NIH HHS P30 CA023100NIAID NIH HHS AI067545NIAID NIH HHS AI072117NIAID NIH HHS K99 AI097286NIAID NIH HHS R00 AI097286NIAID NIH HHS R01 AI067545NIAID NIH HHS R01 AI072117NIAID NIH HHS R37 AI067545
6 · The paper itself

Abstract

Disease outcome is known to be influenced by defined subsets of invariant NKT (iNKT) cells residing in distinct locations within peripheral tissue. However, the factors governing the development of these unique iNKT sublineages during thymic development are unknown. In this study we explored the mechanism by which E protein transcription factors and their negative regulators, the Id proteins, control the development of iNKT sublineages after positive selection. We found that E proteins directly bound the promyelocytic leukemia zinc finger (PLZF) promoter and were required for expression of this lineage-defining transcription factor and for the maturation and expansion of thymic iNKT cells. Moreover, expression of the negative regulators of E proteins, Id2 and Id3, defined distinct iNKT cell sublineages. Id3 was expressed in PLZF(high) NKT2 cells and loss of Id3 allowed for increased thymic iNKT cell expansion and abundance of the PLZF(+) NKT2 sublineage. Id2 was expressed in T-BET(+) NKT1 cells, and both Id proteins were required for the formation of this sublineage. Thus, we provide insight into E and Id protein regulation of iNKT cell proliferation and differentiation to specific sublineages during development in the thymus.

Indexed as

Cell ProliferationAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell DifferentiationInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsKruppel-Like Transcription FactorsMiceMice, TransgenicNatural Killer T-CellsPromyelocytic Leukemia Zinc Finger ProteinThymus GlandBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsIdb2 protein, mouseIdb3 protein, mouseInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsKruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinZbtb16 protein, mouse

Identifiers

PMID24470501
PMCPMC3943952
OpenAlexW2172155558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.